Newrology
A fresh approach to helping patients thrive
A pipeline for patient-kind
Harmony Biosciences’ patient-focused drug development model uses patient insights to inform clinical research programs.
Global Wake-Up Call Helps Bring Narcolepsy to Light
People with this difficult-to-detect sleep disorder can go undiagnosed for years and suffer from stigma. Harmony Biosciences-sponsored article in Scientific American showcases efforts to raise awareness on World Narcolepsy Day.
Oct 30, 2024
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
Oct 29, 2024
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
Oct 29, 2024
HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
available now
Discover our Products
From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most.
The Harmony Team
Meet our leaders who share an uncommon commitment for addressing patients’ unmet medical needs.
Senior Leadership